QUANTIFYING ESTROGEN METABOLISM - AN EVALUATION OF THE REPRODUCIBILITY AND VALIDITY OF ENZYME IMMUNOASSAYS FOR 2-HYDROXYESTRONE AND 16-ALPHA-HYDROXYESTRONE IN URINE
Rg. Ziegler et al., QUANTIFYING ESTROGEN METABOLISM - AN EVALUATION OF THE REPRODUCIBILITY AND VALIDITY OF ENZYME IMMUNOASSAYS FOR 2-HYDROXYESTRONE AND 16-ALPHA-HYDROXYESTRONE IN URINE, Environmental health perspectives, 105, 1997, pp. 607-614
Rapid and simple enzyme immunoassays (EIAs) were recently developed to
measure 2-hydroxyestrone and 16 alpha-hydroxyestrone in unextracted u
rine. The balance between these competing estrogen metabolism pathways
may serve as a biomarker of breast cancer risk. Before testing these
assays in epidemiologic studies, we evaluated their reproducibility, a
nd validity relative to gas chromatography-mass spectroscopy (GC-MS).
Overnight 12-hr urine collections from five midfollicular premenopausa
l women, five midluteal premenopausal women, and five postmenopausal w
omen were aliquoted and stored at -70 degrees C. Two aliquots from eac
h woman were assayed with the EIAs in a random, blinded order, monthly
over 4 months and 1 year later. Reproducibility over 4 months was goo
d for both metabolites in premenopausal women (coefficient of variatio
n = 8-14%) and satisfactory in postmenopausal women (similar to 19%).
Reproducibility over 12 months remained good in premenopausal women, b
ut was poor in postmenopausal women, with mean readings increasing 50
to 100%. Wide variation in estrogen metabolite levels enabled a single
EIA measurement to characterize individual differences among premenop
ausal women in midfollicular (intraclass correlation coefficient = 98-
99%) and midluteal phase (85-91%). A narrower range in metabolite leve
ls among postmenopausal women reduced discrimination (78-82%). The cor
relation between EIA and GC-MS measurement was excellent for both meta
bolites (r > 0.9), except for 2-hydroxyestrone in postmenopausal women
(r = 0.6). Analysis of absolute agreement suggested that both EIAs we
re less sensitive than GC-MS, and each detected nonspecific background
. The tow concentration of estrogen metabolites in urine from postmeno
pausal women may explain the problems with reproducibility and validit
y in this menstrual group. Accordingly, more sensitive EIAs have been
developed and are now being evaluated.